...BRCA2, BRCA1, and mismatch repair genes, with broader testing, such as ATM, for clinical trial eligibility. BRCA2 was re...
...BRCA2 mutation carriers, not hysterectomised, >35 years old and with completed childbearing, were recruited. Some women ...
...BRCA2, making APE2 a prime target for homologous recombination-defective cancers. However, because the function of APE2 ...
...BRCA2 (PALB2) is regarded as a colorectal cancer (CRC) risk gene, but the prognostic implication of PALB2 in CRC remains...
...BRCA2 genes to predict breast and ovarian cancer. We evaluate the proposed model's performance in simulations and real d...
...BRCA2 and 25 at high-risk without mutation. Median follow-up 79 months. 16 patients recently diagnosed and 30 previously...
...BRCA2 tested. Of 34 patients tested, 8.8% had a deleterious mutation (1 BRCA1, 2 TP53), and 5.9% had a BRCA2 VUS. Of wom...
...BRCA2, among others) in 508 (11.5%) survivors. Mutations in homologous recombination (HR) genes were significantly assoc...
...BRCA2 proteins play a role in DNA damage repair, we postulated that taxane-related toxicity is potentially higher and cl...
...BRCA2 is why most women present to familial cancer centers. Despite being assessed as low risk for HBOC, many women proc...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
